Jerry Moran, Stock Trades

U.S. Senator · R · KS

Disclosures through Jul 21

Every stock trade Jerry Moran, has disclosed under the STOCK Act, parsed by Coldpine. Informational only, sourced from public congressional filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Jerry Moran, · Sold $GOOG · May 27 · $1K–$15K

0.34LOW

Disclosure speedx 0.250.30

Trade sizex 0.250.20

Cluster activityx 0.150.30

1 other member traded this name in the same window.

Track recordx 0.35default0.50

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Jerry Moran,

Get an email the moment Jerry Moran, discloses a new trade. Free, no card, no spam.

Follow free →

Disclosed trades

Buys

Sells

Unique tickers

Most-traded tickers

BRK.B5 GOOG2

Recent filingsAll filings, newest first

Periodic transaction report, Jul 21, 20262 trades · BRK.B, GOOG
Periodic transaction report, Jun 25, 20265 trades · BRK.B, GOOG

Recent disclosed trades

Date	Ticker	Asset	Type	Amount
Jun 23	BRK.B	Berkshire Hathaway Inc. New Common Stock	buy	$15K–$50K
Jun 23	GOOG	Alphabet Inc. - Class C Capital Stock	buy	$1K–$15K
May 27	BRK.B	Berkshire Hathaway Inc. New Common Stock	buy	$1K–$15K
May 27	GOOG	Alphabet Inc. - Class C Capital Stock	sell	$1K–$15K
May 27	BRK.B	Berkshire Hathaway Inc. New Common Stock	buy	$1K–$15K
May 27	BRK.B	Berkshire Hathaway Inc. New Common Stock	buy	$1K–$15K
May 27	BRK.B	Berkshire Hathaway Inc. New Common Stock	buy	$1K–$15K

From Coldpine Research

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →